GlassScriptPhysician profile
Sean Robert Kelly
NPI 1174592760
$5,775.56
in general payments reported to CMS, 2019-2025
37 companies · $667 in 2025
The $667 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $1,122 · 2021: $1,012 · 2022: $764 · 2023: $704 · 2024: $406 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,744 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,743.80 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,143.63 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $955.82 | 2019-2025 | |
| Glaxosmithkline, LLC. | $600.14 | 2019-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $509.12 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $333.05 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $290.55 | 2019-2024 | Farxiga, Breztri |
| Amgen INC. | $290.23 | 2019-2024 | Prolia, Evenity, Repatha |
| Janssen Pharmaceuticals, INC | $224.96 | 2019-2023 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.73 | 2019-2025 | Jardiance, Tradjenta, Stiolto Respimat |
| Merck Sharp & Dohme LLC | $155.21 | 2019-2025 | Capvaxive, M-M-R II, Gardasil 9 |
| Amarin Pharma, INC. | $114.25 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $111.10 | 2021-2025 | |
| Medtronic, INC. | $90.93 | 2022 | |
| Abbott Laboratories | $66.04 | 2019-2022 | |
| Exact Sciences Corporation | $62.29 | 2023 | Cologuard Collection Kit |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.